Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming

Obstetrics and Gynecology

Volumn 92, Issue 5, 1998, Pages 795-798

  Singh, Kuldip ^a   Fong, Y F ^a   Prasad, R N V ^a   Dong, F ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GEMEPROST; MISOPROSTOL;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; HUMAN; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX DILATATION; VACUUM ASPIRATION; VAGINA BLEEDING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; CERVICAL RIPENING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MISOPROSTOL; PARITY; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 0031792891     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00281-6     Document Type: Article

References (11)

1. Ngi S.W., Au Yeung K.C., Lao T., Ho P.C. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women, in the sixth to twelfth week of gestation. Contraception. 51:1995;347-350.
2. Schulz K.F., Grimes D.A., Cates W.J. Measures to prevent cervical injury during suction curettage abortion. Lancet. 1:1983;1182-1184.
3. Grimes D.A., Schulz K.F., Cates W.J. Prevention of uterine perforation during curettage abortion. JAMA. 251:1984;2108-2111.
4. 1 analogues, misoprostol and gemeprost. Lancet. 343:1994;1207-1209.
5. Misoprostol and legal medical abortion [editorial]. Lancet. 38:1991;1241-1242.
6. Lawri A., Penney G., Templeton A. A randomised comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol. 103:1996;1117-1119.
7. Royal College of Obstetricians and Gynaecologists. Guidelines on induced abortion. 11:1997;1-10.
8. Meinert CL. Clinical trials: Design, conduct and analysis. Oxford University Press, 1986:96-101.
9. Ficicioglu C., Tasdemir M., Tasdemir S. Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks of gestation. Acta Obstet Gynecol Scand. 75:1996;54-56.
10. Bugalho A., Bique C., Almeida L., Bergstrom S. Application of vaginal misoprostol before cervical dilatation to facilitate first trimester pregnancy interruption. Obstet Gynecol. 83:1994;729-731.
11. Bugalho A., Faundes A., Jamisse L., Usfa M., Maria E., Bique C. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception. 53:1996;244-246.